in this activity, participants should be able to:
the challenges in caring for patients with CRI|
treatment options used to improve CRI patient outcomes|
the latest clinical data and developments in managing anemia in CRI patients|
|Daniel W. Coyne,
Associate Professor of Medicine, Washington University; Director,
Hemodialysis, Chromalloy American Kidney Center; Director, Renal Outpatient Renal
Clinics; Co-director, Renal Fellowship Training Program, St. Louis, MO.
Clinical Professor of Medicine, Tulane University, New Orleans, LA. Assistant
Clinical Professor of Medicine, Louisiana State University of New Orleans, LA.
Associate Section Head, Hemodialysis Units Director, Metabolic Bone and Stone
Clinics. Director, Nephrology Research, Ochsner Foundation Hospital, New Orleans,
ACCREDITATION / DESIGNATION
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
(ACCME) through the sponsorship of the Medical Education Resources, Inc.
Medical Education Resources, Inc. is accredited by the ACCME to sponsor
continuing medical education for physicians and takes responsibility for the content,
quality, and scientific integrity of this CME activity.
Resources, Inc. designates this educational activity for a maximum of 1.25 hours
in Category 1 credit toward the AMA Physician's Recognition Award. Each physician
should claim only those hours of credit that he/she actually spent in the educational
This CE activity is approved for 1.25 contact hours. Medical Education Resources, Inc. is approved as a provider of continuing education
in nursing (CNE) by the Colorado Nurses Association, which is accredited as an
approver of CNE by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider #CEP
12299, for 1.25 contact hours.
INSTRUCTIONS FOR CME CREDIT :|
To earn CME credit
for viewing the lectures, please print and complete the CME Posttest questions
and return with the completed Evaluation Form to Medical Education Resources,
Inc. via fax at (303) 798-5731 or mail at 1500 West Canal Court, Suite 500, Littleton,
|Post-test and Evaluation Form are at
this link, but you must listen to all four talks from this symposium
prior to completing the test.|
program is designed for clinicians who are involved in the care of chronic renal
faculty participating in continuing medical education programs are expected to
disclose to the program audience any real or apparent conflict of interest related
to the subject under discussion. The faculty disclosure information is as follows:
DISCLOSURE STATEMENTS :|
Daniel W. Coyne, MD, has received grants/research support from Amgen and is a
consultant and Speaker Bureau participant for Watson Pharmaceuticals, Inc.
Jill S. Lindberg,
MD, has received grants/research support from and is a consultant for Genzyme,
Amgen, and BCI.
activity contains discussion of published and/or investigational uses of agents
that are not indicated by FDA. Medical Education Resources, ASN, HDCN do
not recommend the use of any agent outside of the labeled indications. Please
refer to the official prescribing information for each product for discussion
of approved indications, contraindications and warnings.
DISCLOSURE OF UNLABELED USE ASN/HDCN (if applicable):|
of the agents overviewed in this virtual symposium will be discussed in the context
of uses for which they have not been approved by the FDA.